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Milk hydrolysis products may retain their allergenic reactivity 
Introduction 
Milk allergy is one of the most common allergies in small 
children. Extensively hydrolysed milk formulas are therefore 
an important source of nutrients for infants with cow’s milk 
allergy and for infants being predisposed for allergy and not 
being breastfed. 
 
The aim of this study was to investigate two extensively 
hydrolysed milk whey products for their sensitising and 
reacting capacity in a Brown Norway (BN) rat model. 
 
 
Methods 
BN rats (12/group) were immunised i.p. three times without 
the use of adjuvant with 200 µg of either PBS (control), intact 
β-lactoglobulin (BLG), hydrolysed BLG or an extensively 
hydrolysed milk whey product, commercially available and 
used as protein source in infant formulas. 
 
 
 
 
 
 
Hydrolysed BLG and the extensively hydrolysed milk whey 
proteins were analysed for residual intact BLG by RP-HPLC, 
aggregation profiles by gel permeation chromatography (GPC) 
and peptide masses by MALDI-TOF mass spectrometry (MS). 
 
Sera from BN rats were analysed for specifik IgG1, IgG2a and 
IgE titres and the avidity of the antibodies were measured in 
ELISAs. 
 
Results 
RP-HPLC showed that no residual intact BLG was left in the 
hydrolysates. Hydrolysed BLG and hydrolysed whey proteins 
both had a degree of hydrolysis (DH) of 28 and MALDI-TOF MS 
showed that peptides in hydrolysed BLG were ≤ 3.5 kDa and 
that peptides in hydrolysed whey proteins were ≤ 2.5 kDa, of 
which more than 90% were between 0.5 and 2.0 kDa (Fig. 1). 
However, GPC profiles indicated that > 40% of the hydrolysed 
BLG was in aggregated complexes of up to Mr 29 and that > 
55% of hydrolysed whey proteins were in aggregated 
complexes of up to Mr 22. 
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The study showed that while intact BLG could induce a 
statistically significant antibody response, both hydrolysed BLG 
and hydrolysed whey proteins had no sensitising capacity (Fig. 
2). However, IgG1 antibodies from rats immunised with intact 
BLG could still react with both the hydrolysed BLG and 
hydrolysed whey proteins, in a statistically significant way. Also 
IgE antibodies from 1/3 of these rats were able to react with 
the extensively hydrolysed milk whey protein product. 
Conclusion 
The extensively hydrolysed milk products showed no 
sensitising capacity. However, they retained their reacting 
activity and hydrolysed whey proteins were still able to bind 
IgE from rats sensitised to intact BLG.  
These results resemble observation seen in humans, where 
infants allergic to cow’s milk may react to extensively 
hydrolysed milk formulas. 
 
Finding like these may lead to development of new standards 
for extensively hydrolysed infant formulas, where higher 
demands should be made on the protein chemical 
characteristics of the formula, based on peptide sizes and state 
of aggregation. 
 
 
Results from avidity measurements indicated that antibodies 
raised in rats immunised with intact BLG had a statistically 
significant higher avidity towards the intact BLG compared to 
both hydrolysed BLG and hydrolysed whey proteins (Fig. 3). 
Also shown was that the avidity of IgE was higher than the 
avidity of IgG1. 
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 Fig. 1. Frequency distribution of peptide sizes, where each bar correspond to the                                    
 size interval of 0.5 kDa. 
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Fig. 2. Scatter plot of specific antibody response of individual rats. 
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Fig. 3. Scatter plot 
of avidity of specific 
IgG1 and IgE 
antibodies, 
demonstrated by 
the concentration of 
potassium 
thiocyanate (KSCN) 
needed for 
inhibition of 50% of 
the response. 
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